Publications

Detailed Information

Artificial nutrition and hydration in terminal cancer patients: the real and the ideal

Cited 16 time in Web of Science Cited 14 time in Scopus
Authors

Oh, Do Youn; Kim, Jee Hyun; Lee, Se Hoon; Kim, Dong WanIm, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung Jue; Kim, Noe Kyeong

Issue Date
2007-06
Publisher
Springer Verlag
Citation
Supportive Care in Cancer, Vol.15 No.6, pp.631-636
Abstract
Introduction: To better understand current practice relating to artificial nutrition/hydration in terminal cancer patients, we enrolled terminal cancer patients who were admitted at Seoul National University Boramae Hospital for supportive care only and who died with a duration of hospital stay to death of more than 1 week between 2003 and 2004. We detailed oral intake and intravenous nutrition/hydration status on admission, 1 week after admission, and 2 days before death. Administered calories and changes in these according to time and "DNR" (do-not-resuscitate) status were noted. Results: Of the total 165 patients, oral intake was possible in 84 patients (50.9%) on admission, in 79 patients (47.8%) on 1 week after admission, and in 29 patients (17.5%) 2 days before death (p < 0.01). Intravenous nutrition/hydration was administered to 133 patients (80.6%) on admission, to 125 patients (75.7%) at I week, and to 137 patients (83.0%) 2 days before death (p=0.7). The calories administered to the patient by oral intake were 393 kcal on admission, 353 kcal I week after admission, and 89 kcal 2 days before death. In addition, the calories delivered by intravenous fluid were 369, 386 and 465 kcal, respectively. Near to death, calories by oral intake continuously reduced (p < 0.01) and intravenous calories continuously increased (p=0.04), but total administered calories reduced (p=0.03). Intravenous nutrition/hydration stopped after the attainment of the advance directive of DNR in 9% of patients. Conclusion: This study showed the high prevalence of artificial nutrition/hydration, especially intravenous infusion, in Korean terminal cancer patients compared with situation in other countries. More studies are needed to verify the efficacy of artificial nutrition/hydration in terminal cancer patients.
ISSN
0941-4355
Language
English
URI
https://hdl.handle.net/10371/24566
DOI
https://doi.org/10.1007/s00520-006-0184-9
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area DNA 손상 반응 타겟 물질의 면역조절 효과, Effect of DNA damage response target substances on immunomodulatory action, Efficacy and biomarker validation studies of targeted therapeutics, Resistance mechanisms according to targeted therapeutics, 표적 항암제 내성 기전 연구, 표적 항암제의 효과 검증 및 바이오마커 규명

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share